Drug Shortages

Recreation of FDA drug shortage list with status updates in 2020
WIZMED sources is data from the FDA, Dailymed, Medicaid data and other data sources and uses calculations to attempt to align datasets. The data feeds may run night, weekly and/or quarterly depending on data source. WIZMED nor any of its agencies, contractors, subcontractors or employees does not make any warranties, expressed or implied, with respect to data contained in these databases or files, and, furthermore, assume no liability for any party's use, or the results of such use, of any part of the database or files.

Recreated Drug Shortage List for updates in 2020 See Updates Since 2017

Product Last Update Initial Post Date Company Strength Status Availablity Reason
Abiraterone Acetate Tablets 2020-06-05 2020-06-05 Janssen Research and Developme 250 mg tablets (NDC 57894-155-12) To be Discontinued
Acetaminophen/Tramadol Hydroch 2020-04-01 2020-04-01 Janssen Pharmaceuticals 325 mg/1 unit || 37.5 mg/1 unit (NDC 50458-650-60) To be Discontinued
Acrivastine and Pseudoephedrin 2020-06-02 2020-06-02 Endo Pharmaceuticals, Inc. Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10) To be Discontinued
Alfentanil Injection 2020-03-25 2020-03-25 Hospira, Inc. 1 mg/2 mL (500 mcg/mL) Glass Ampul (NDC 00409-2266-02) To be Discontinued
Alfentanil Injection 2020-03-25 2020-03-25 Hospira, Inc. 2.5 mg/5 mL (500 mcg/mL) Glass Ampul (NDC 00409-2266-05) To be Discontinued
Amoxapine Tablets 2020-07-06 2020-03-09 Teva Pharmaceuticals 50 mg, 100 tablets (NDC 0591-5714-01) Current Unavailable. Estimated supply availability July 2020. Other
Amoxapine Tablets 2020-07-06 2020-03-09 Teva Pharmaceuticals 25 mg, 100 tablets (NDC 0591-5713-01) Current Unavailable. Estimated supply availability July 2020. Other
Amoxapine Tablets 2020-07-06 2020-03-09 Teva Pharmaceuticals 100 mg, 100 tablets (NDC 0591-5715-01) Current Unavailable. Estimated supply availability July 2020. Other
Amoxapine Tablets 2020-07-06 2020-03-09 Teva Pharmaceuticals 150 mg, 100 tablets (NDC 0591-5716-01) Current Unavailable. Estimated supply availability July 2020. Other
Anastrozole Tablets 2020-01-21 2020-01-21 Apotex Corp. 1 mg tablets (NDC 60505-2985-3) To be Discontinued
Argatroban Injection 2020-01-15 2020-01-15 Novartis 250 mg/2.5 mL (100 mg/mL), single dose vial (NDC 0078-0930-61) To be Discontinued
Aspirin/Dipyridamole (Aggrenox 2020-05-26 2020-05-26 Boehringer Ingelheim Pharmaceu 25mg/200mg capsules (NDC 0597-0001-60) To be Discontinued
Bacitracin Ophthalmic Ointment 2020-04-29 2019-10-23 Perrigo Pharmaceuticals Bacitracin Ophthalmic Ointment 3.5 g (NDC 0574-4022-35) Resolved
Bethanechol Chloride Tablets 2020-01-13 2020-01-13 Teva Pharmaceuticals 5 mg capsules (NDC 51285-697-02) To be Discontinued
Bethanechol Chloride Tablets 2020-01-13 2020-01-13 Teva Pharmaceuticals 10 mg capsules (NDC 51285-690-02) To be Discontinued
Bethanechol Chloride Tablets 2020-05-01 2020-05-01 Teva Pharmaceuticals 10 mg (NDC 50111-324-01) To be Discontinued
Bethanechol Chloride Tablets 2020-05-01 2020-05-01 Teva Pharmaceuticals 5 mg (NDC 50111-323-01) To be Discontinued
Bethanechol Chloride Tablets 2020-05-01 2020-05-01 Teva Pharmaceuticals 25 mg (NDC 50111-325-01) To be Discontinued
Bethanechol Chloride Tablets 2020-05-01 2020-05-01 Teva Pharmaceuticals 50 mg (NDC 50111-326-01) To be Discontinued
Betrixaban (Bevyxxa) Capsules 2020-05-01 2020-05-01 Portola Pharmaceuticals, Inc. 40 mg capsules (NDC 69853-0202-1) To be Discontinued
Betrixaban (Bevyxxa) Capsules 2020-05-01 2020-05-01 Portola Pharmaceuticals, Inc. 80 mg capsules (NDC 69853-0201-1) To be Discontinued
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 10mg, 100 (NDC 69238-1117-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 10mg, 500 (NDC 69238-1117-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 15mg, 100 (NDC 69238-1118-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 15mg, 500 (NDC 69238-1118-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 15mg, 60 (NDC 69238-1118-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 30mg, 60 (NDC 69238-1119-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 5mg, 100 (NDC 69238-1115-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 5mg, 500 (NDC 69238-1115-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Amneal Pharmaceutical 7.5mg, 100 (NDC 69238-1116-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 5 mg, 100 count bottle (NDC 23155-023-01 Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 5 mg, 500 count bottle (NDC 23155-023-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 10 mg, 100 count bottle (NDC 23155-024-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 10 mg, 500 count bottle (NDC 23155-024-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 15 mg, 60 count bottle (NDC 23155-025-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 15 mg, 100 count bottle (NDC 23155-025-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 15 mg, 180 count bottle (NDC 23155-025-08) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 15 mg, 500 count bottle (NDC 23155-025-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 30 mg, 60 count bottle (NDC 23155-097-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Heritage Pharmaceuticals d/b/a 30 mg, 500 count bottle (NDC 23155-097-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 15 mg, 60 count bottle (NDC 64380-743-03) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 15 mg, 180 count bottle (NDC 64380-743-18) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 5 mg, 100 count bottle (NDC 16729-200-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 5 mg, 500 count bottle (NDC 16729-200-16) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 7.5 mg, 100 count bottle (NDC 16729-201-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 10 mg, 100 count bottle (NDC 16729-202-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 10 mg, 500 count bottle (NDC 16729-202-16) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 15 mg, 60 count bottle (NDC 16729-203-12) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 15 mg, 100 count bottle (NDC 16729-203-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Accord Healthcare Inc. 30 mg, 60 count bottle (NDC 16729-289-12) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 7.5 mg, 100 count bottle (NDC 49884-725-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 7.5 mg, 500 count bottle (NDC 49884-725-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 5 mg, 100 count bottle (NDC 0378-1140-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 5 mg, 500 count bottle (NDC 0378-1140-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 5 mg, unit-dose blister pack, 100 count (NDC 51079-985-20) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 7.5 mg, 100 count bottle (NDC 0378-1145-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 10 mg, 100 count bottle (NDC 0378-1150-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 10 mg, 500 count bottle (NDC 0378-1150-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 10 mg, unit-dose blister pack, 100 count (NDC 51079-986-20) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 15 mg, 60 count bottle (NDC 0378-1165-91) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 15 mg, 180 count bottle (NDC 0378-1165-80) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 15 mg, 500 count bottle (NDC 0378-1165-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 15 mg, unit-dose blister pack, 100 count (NDC 51079-960-20) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 30 mg, 60 count bottle (NDC 0378-1175-91) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Mylan Pharmaceuticals Inc. 30 mg, unit-dose blister pack, 100 count (NDC 51079-994-20) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 5 mg, 100 count bottle (NDC 64380-741-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 5 mg, 500 count bottle (NDC 64380-741-07) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 5 mg, 1000 count bottle (NDC 64380-741-08) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 7.5 mg, 100 count bottle (NDC 64380-787-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 10 mg, 100 count bottle (NDC 64380-742-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 10 mg, 500 count bottle (NDC 64380-742-07) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 10 mg, 1000 count bottle (NDC 64380-742-08) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Strides Pharma Inc. 30 mg, 60 count bottle (NDC 64380-744-03) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 5 mg, 100 count bottle (NDC 0093-0053-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 5 mg, 500 count bottle (NDC 0093-0053-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 10 mg, 100 count bottle (NDC 0093-0054-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 10 mg, 500 count bottle (NDC 0093-0054-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 15 mg, 100 count bottle (NDC 0093-1003-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 15 mg, 500 count bottle (NDC 0093-1003-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 30 mg, 60 count bottle (NDC 0093-5200-06) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Teva Pharmaceuticals 30 mg, 500 count bottle (NDC 0093-5200-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 5 mg, 100 count bottle (NDC 68382-180-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 5 mg, 500 count bottle (NDC 68382-180-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 10 mg, 100 count bottle (NDC 68382-181-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 10 mg, 500 count bottle (NDC 68382-181-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 15 mg, 100 count bottle (NDC 68382-182-01) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 15 mg, 500 count bottle (NDC 68382-182-05) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 30 mg, 60 count bottle (NDC 68382-183-14) Resolved
Buspirone HCl Tablets 2020-01-16 2018-11-21 Zydus Pharmaceuticals USA Inc. 30 mg, 500 count bottle (NDC 68382-183-05) Resolved
Busulfan Injection 2020-05-06 2020-05-06 Teva Pharmaceuticals 6 mg/mL (NDC 45963-640-77) To be Discontinued
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Mylan Specialty Soma, 250 mg 30 count bottle (NDC 0037-2250-30) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Ingenus Pharmaceuticals LLC 350 mg, 100 count tablets (NDC 50742-656-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 100 tablets (NDC 16714-510-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 500 tablets (NDC 16714-510-02) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 1000 tablets (NDC 16714-510-03) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 100 tablets (NDC 61442-451-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 500 tablets (NDC 61442-451-05) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 1000 tablets (NDC 61442-451-10) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 100 tablets (NDC 59746-705-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 500 tablets (NDC 59746-705-05) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Orient Pharma Co., Ltd 350 mg, 1000 tablets (NDC 59746-705-05) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Endo Pharmaceuticals, Inc. 100’s count bottle (NDC 00603-2582-21) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Endo Pharmaceuticals, Inc. 500's count bottle (NDC 00603-2582-28) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Endo Pharmaceuticals, Inc. 100's count bottle (NDC 00603-2582-32) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Mylan Specialty Soma, 250 mg, 30 count bottle (NDC 0037-2250-30); 100 count bottle (NDC 0037-2250-10) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Mylan Specialty Soma, 350 mg, 100 count bottle (NDC 0037-2001-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Teva Pharmaceuticals 350 mg, 100 count (NDC 0591-5513-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Teva Pharmaceuticals 350 mg, 500 count (NDC 0591-5513-05) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 Teva Pharmaceuticals 350 mg, 1000 count (NDC 0591-5513-10) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 100 count (NDC 50228-109-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 500 count (NDC 50228-109-05) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 1000 count (NDC 50228-109-10) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 1000 count (NDC 60429-508-10) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 100 count (NDC 42543-700-01) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 500 count (NDC 42543-700-05) Resolved
Carisoprodol Tablets, USP 2020-05-19 2019-04-22 ScieGen Pharmaceuticals, Inc. 350 mg, 1000 count (NDC 42543-700-10) Resolved
Cefdinir Capsules 2020-07-09 2020-07-09 Sandoz 300 mg capsules (NDC 0781-2176-60) To be Discontinued
Cefotetan Disodium Injection 2020-03-31 2020-03-31 Teligent Pharma, Inc. Cefotan 1g Vial 10 (NDC 52565-0052-10) To be Discontinued
Chloroquine Phosphate Tablets 2020-05-08 2020-03-31 Natco Pharma Limited 250 mg, 50 count bottle (NDC 64980-177-50); distributed by Rising Pharmaceuticals, to order contact: 201-961-9000 Resolved
Chloroquine Phosphate Tablets 2020-05-08 2020-03-31 Natco Pharma Limited 500 mg, 25 count bottle (NDC 64980-178-02); distributed by Rising Pharmaceuticals, to order contact: 201-961-9000 Resolved
Chlorothiazide Injection 2020-04-08 2020-04-08 Mylan Institutional 500 mg (NDC 67457-263-30) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 1 mg (NDC 0056-0169-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 1 mg (NDC 0056-0169-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 2 mg (NDC 056-0170-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 2 mg (NDC 0056-0170-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 2 1/2 mg (NDC 0056-0176-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 2 1/2 mg (NDC 0056-0176-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 3 mg (NDC 0056-0188-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 3 mg (NDC 0056-0188-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 4 mg (NDC 0056-0168-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 4 mg (NDC 0056-0168-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 5 mg (NDC 0056-0172-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 5 mg (NDC 0056-0172-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 6 mg (NDC 0056-0189-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 6 mg (NDC 0056-0189-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 7 1/2 mg (NDC 0056-0173-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 7 1/2 mg (NDC 0056-0173-75) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 10 mg (NDC 0056-0174-70) To be Discontinued
Coumadin Tablets 2020-04-24 2020-04-24 Bristol Myers Squibb Co. 10 mg (NDC 0056-0174-75) To be Discontinued
Darifenacin Extended-release T 2020-06-26 2020-06-26 Teva Pharmaceuticals 7.5 mg, 30 count bottle (NDC 0591-4375-30) To be Discontinued
Darifenacin Extended-release T 2020-06-26 2020-06-26 Teva Pharmaceuticals 15 mg, 30 count bottle (NDC 0591-4380-30) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-17 2020-06-04 Teva Pharmaceuticals Extended release, 7.5 mg, 90 count bottle (NDC 0591-4375-19) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-17 2020-06-04 Teva Pharmaceuticals 15 mg, 30 count bottle (NDC: 0591-4380-30) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 15 mg, Bottle of 30 (NDC 0430-0171-15) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 15 mg, Bottle of 90 (NDC 0430-0171-23) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 15 mg , 337500 TABLETS in 1 DRUM (NDC 0430-0171-00) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 15 mg, Bottle of 7 (NDC 0430-0171-96) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 0430-0170-15) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 7.5 mg Bottle of 90 (NDC 0430-0170-23) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 7.5 mg, 337500 TABLETS in 1 DRUM (NDC 0430-0170-00) To be Discontinued
Darifenacin Hydrobromide Table 2020-06-04 2020-06-04 Allergan Extended-Release Tablet, 7.5 mg, Bottle of 7 (NDC 0430-0170-96) To be Discontinued
Demeclocycline Hydrochloride T 2020-04-21 2020-04-21 Teva Pharmaceuticals 150 mg 100 count (NDC 0555-0701-02) To be Discontinued
Demeclocycline Hydrochloride T 2020-04-21 2020-04-21 Teva Pharmaceuticals 300 mg 48 count (NDC 0555-0702-84) To be Discontinued
Dexmedetomidine Injection 2020-04-13 2020-04-13 Sandoz 200 mcg/2 mL (100 mcg/mL) vial, box of 10 (NDC 0781-3297-95) To be Discontinued
Dexrazoxane Injection 2020-02-26 2017-07-14 Gland Pharma 500 mg per vial (NDC 72266-101-01); distributed by Fosun Pharma USA Inc. Resolved
Dexrazoxane Injection 2020-02-26 2017-07-14 Gland Pharma 500 mg per vial (NDC 51991-942-98); distributed by Breckenridge Pharmaceutical, Inc. Resolved
Dexrazoxane Injection 2020-02-26 2017-07-14 Gland Pharma 500 mg per vial (NDC 47781-578-07); distributed by Alvogen, Inc. Resolved
Dexrazoxane Injection 2020-02-26 2017-07-14 Hikma Pharmaceuticals USA, Inc 250 mg per vial (NDC 0143-9247-01); distributed by West-Ward Resolved
Dexrazoxane Injection 2020-02-26 2017-07-14 Hikma Pharmaceuticals USA, Inc 500 mg per vial (NDC 0143-9248-01); distributed by West-Ward Resolved
Dexrazoxane Injection 2020-02-26 2017-07-05 Mylan Institutional 250 mg Kit (NDC 67457-207-25) Resolved
Dexrazoxane Injection 2020-02-26 2017-07-05 Mylan Institutional 500 mg Kit (NDC 67457-208-50) Resolved
Dexrazoxane Injection 2020-02-26 2017-07-05 Pfizer Pharmaceuticals Zinecard 250 mg; Single Dose Vial (NDC 0013-8717-62) Resolved
Dexrazoxane Injection 2020-02-26 2017-07-14 Clinigen Healthcare Ltd Totect® (Dexrazoxane) for injection; 1 vial (500 mg)(NDC 66220-110-01); distributed by Cumberland Pharmaceuticals Resolved
Diclofenac Sodium Topical Gel 2020-02-13 2020-02-13 Endo Pharmaceuticals, Inc. 1% topical gel (NDC 49884-935-47) To be Discontinued
Diclofenac Sodium Topical Solu 2020-05-06 2020-05-06 Apotex Corp. 2% topical solution (NDC 60505-0399-5) To be Discontinued
Didanosine Delayed-Release Cap 2020-02-24 2020-02-24 Bristol Myers Squibb Co. VIDEX EC Cpasules, 125 mg (NDC 0087-6671-17) To be Discontinued
Didanosine Delayed-Release Cap 2020-02-24 2020-02-24 Bristol Myers Squibb Co. VIDEX EC Capsules, 200 mg (NDC 0087-6672-17) To be Discontinued
Didanosine Delayed-Release Cap 2020-02-24 2020-02-24 Bristol Myers Squibb Co. VIDEX EC Capsules, 250 mg (NDC 0087-6673-17) To be Discontinued
Didanosine Delayed-Release Cap 2020-02-24 2020-02-24 Bristol Myers Squibb Co. VIDEX EC Capsules, 400 mg (NDC 0087-6674-17) To be Discontinued
Didanosine Delayed-Release Cap 2020-02-24 2020-02-24 Bristol Myers Squibb Co. VIDEX PED PWD 2 g (1 bottle) 4 oz (NDC 0087-6632-41) To be Discontinued
Didanosine Delayed-Release Cap 2020-02-24 2020-02-24 Bristol Myers Squibb Co. VIDEX PED PWD 4 g (1 bottle) 8 oz (NDC 0087-6633-41) To be Discontinued
Diltiazem Hydrochloride 2020-02-07 2018-02-21 Akorn Pharmaceuticals Diltiazem HCl Injection (Premier) 25 mg / 5 mL, 10 mL, 10 vials (NDC 17478-0817-10) To be Discontinued
Diltiazem Hydrochloride 2020-02-07 2018-02-21 Akorn Pharmaceuticals Diltiazem HCl Injection (Premier) 5 mg / mL, 25 mL, 1 vial (NDC 17478-0817-25) To be Discontinued
Diltiazem Hydrochloride 2020-02-07 2018-02-21 Akorn Pharmaceuticals Diltiazem HCl Injection (Premier) 5 mg / mL, 25 mL, 10 vials (NDC 17478-0817-26) To be Discontinued
Diltiazem Hydrochloride 2020-02-07 2018-02-21 Akorn Pharmaceuticals Diltiazem HCl Injection (Premier) 0.5 mg / mL, 30 gram, 10 vials (NDC 17478-0817-05) To be Discontinued
Diltiazem Hydrochloride ER (Tw 2020-02-20 2018-10-18 Mylan Pharmaceuticals Inc. 60 mg (NDC 0378-6060-01) Resolved
Diltiazem Hydrochloride ER (Tw 2020-02-20 2018-10-18 Mylan Pharmaceuticals Inc. 90 mg (NDC 0378-6090-01) Resolved
Diltiazem Hydrochloride ER (Tw 2020-02-20 2018-10-18 Mylan Pharmaceuticals Inc. 120 mg (NDC 0378-6120-01) Resolved
Dobutamine Hydrochloride Injec 2020-04-03 2017-11-06 Pfizer Pharmaceuticals 500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54) To be Discontinued
Docetaxel Injection 2020-03-31 2020-03-31 Teva Pharmaceuticals 20 mg/mL (NDC 45963-790-56) To be Discontinued
Donepezil Hydrochloride Tablet 2020-02-13 2020-02-13 Teva Pharmaceuticals 23mg tablets (NDCs 0228-4529-03 and 0228-4529-09) To be Discontinued
Doxorubicin Hydrochloride Inje 2020-03-05 2020-03-05 Fresenius Kabi USA, LLC 2 mg/mL, 10 mL single-dose vial (NDC 63323-883-10) To Be Discontinued
Dutasteride Capsules 2020-01-07 2020-01-07 Apotex Corp. 0.5 mg capsules (NDCs 60505-3877-9 and 60505-3877-3) To be Discontinued
Entecavir Tablets 2020-02-14 2020-02-14 Teva Pharmaceuticals 0.5mg tablets (NDCs 0093-5786-98 and 0093-5786-56) To be Discontinued
Entecavir Tablets 2020-02-14 2020-02-14 Teva Pharmaceuticals 1mg tablets (NDC 0093-5787-56) To be Discontinued
Eprosartan Mesylate Tablets 2020-03-16 2019-03-11 Mylan Pharmaceuticals Inc. Eprosartan Mesylate 600mg T 30s (NDC 0378-6629-93) To be Discontinued
Ergotamine Tartrate and Caffei 2020-07-02 2020-07-02 Sandoz 1mg/100mg (NDC 0781-5405-01) To be Discontinued
Ethinyl Estradiol; Norgestrel 2020-05-08 2020-05-08 Teva Pharmaceuticals 0.05 mg; 0.5mg (NDC 52544-848-28) To be Discontinued
Etomidate (Amidate) Injection 2020-03-24 2020-03-24 Hospira, Inc. 40 mg/20 mL (2 mg/mL) Abboject Glass Syringe (NDC 00409-8060-29) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 100 ug/1 h (NDC 50458-094-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 75 ug/1 h (NDC 50458-093-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 50 ug/1 h (NDC 50458-092-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 25 ug/1 h (NDC 50458-091-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 100 ug/1 unit (NDC 50458-106-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 75 ug/1 unit (NDC 50458-105-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 50 ug/1 unit (NDC 50458-104-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 25 ug/1 unit (NDC 50458-102-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 12.5 ug/1 unit (NDC 50458-101-05) To be Discontinued
Fentanyl (Duragesic 100, 12, 2 2020-04-01 2020-04-01 Janssen Pharmaceuticals 12.5 ug/1 h (NDC 50458-090-05) To be Discontinued
Fludarabine Phosphate for Inje 2020-02-10 2020-02-10 Hospira, Inc. 50 mg Single Dose Glass Fliptop Vial (NDC 61703-0344-18) To be Discontinued
Fluorouracil Injection 2020-02-20 2020-02-10 Teva Pharmaceuticals 5g/100mL injection (NDC 0703-3019-12) To be Discontinued
Fluorouracil Injection 2020-02-20 2020-02-10 Teva Pharmaceuticals 2.5g/50mL injection (NDC 0703-3018-12) To be Discontinued
Fluorouracil Injection 2020-02-20 2020-02-10 Teva Pharmaceuticals 50mg/1mL injection (NDC 0703-3015-13) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-08 2019-12-16 Apotex Corp. 200 mg/5.26 mL (38 mg/mL), single dose vial (NDC 60505-6113-6) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-08 2019-12-16 Apotex Corp. 1 g/26.3 mL (38 mg/mL), single dose vial (NDC 60505-6114-0) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-08 2019-12-16 Apotex Corp. 2 g/52.6 mL (38 mg/mL), single dose vial (NDC 60505-6115-2) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-16 2019-12-16 Teva Pharmaceuticals 1 g, single dose vial (NDC 45963-619-59) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-16 2019-12-16 Teva Pharmaceuticals 200 mg/5.26 mL (38 mg/mL), single dose vial (NDC 45963-623-57) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-16 2019-12-16 Teva Pharmaceuticals 1 g/26.3 mL (38 mg/mL), single dose vial (NDC 45963-624-58) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-16 2019-12-16 Teva Pharmaceuticals 2 g/52.6 mL (38 mg/mL), single dose vial (NDC 45963-636-60) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-07 2019-12-16 Teva Pharmaceuticals 200 mg, single dose vial (NDC 45963-612-57) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-01-07 2019-12-16 Teva Pharmaceuticals 2 g, single dose vial (NDC 45963-620-60) To be Discontinued
Gemcitabine Hydrochloride Inje 2020-06-26 2019-12-16 Mylan Institutional 200 mg, single dose vial (NDC 67457-464-20) To be Discontinued
Glipizide Tablets 2020-05-28 2020-05-28 Teva Pharmaceuticals 5mg tablets (NDC 0591-0460-10), (NDC 0591-0460-05), (NDC 0591-0460-01) To be Discontinued
Glipizide Tablets 2020-05-28 2020-05-28 Teva Pharmaceuticals 10mg tablets, (NDC 0591-0461-10), (NDC 0591-0461-01), (NDC 0591-0461-05) To be Discontinued
Glycopyrrolate (Seebri Neohale 2020-03-10 2020-03-10 Sunovion Pharmaceuticals Inc. 15.6mcg (NDCs 63402-815-06, 63402-815-12, and 63402-815-60) To be Discontinued
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Teva Pharmaceuticals 200 mg, 500 count bottle (NDC 0591-3041-05) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Sandoz 200 mg, 100 count bottle (NDC 16714-753-01) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Alkaloida Chemical Co. Zrt. 200 mg, 100 count bottle (NDC 57664-761-88); 500 count bottle (NDC 57664-761-13) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Amneal Pharmaceutical 200 mg, 100 count bottle (NDC 69238-1544-1) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Appco Pharma LLC 200 mg, 100 count bottle (NDC 43598-721-01); 500 count bottle (NDC 43598-721-05) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Concordia Pharmaceuticals Inc. 200 mg, 100 count bottle (NDC 66993-057-02); 500 count bottle (NDC 66993-057-04) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Concordia Pharmaceuticals Inc. Plaquenil 200 mg, 100 count bottle (NDC 59212-562-10) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Laurus Labs Limited 200 mg, 100 count bottle (NDC42385-927-01); 500 count bottle (NDC 42385-927-05) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Mylan Pharmaceuticals Inc. 200 mg, 100 count bottle (NDC 0378-0373-01) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Sandoz 200 mg, 100 count bottle (NDC 0781-5994-01); 500 count bottle (NDC 0781-5994-05) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Teva Pharmaceuticals 200 mg, 100 count bottle (NDC 0591-3041-01) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Zydus Pharmaceuticals USA Inc. 200 mg, 100 count bottle (NDC 68382-096-01); 500 count bottle (NDC 68382-096-05) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Zydus Pharmaceuticals USA Inc. 200 mg, 100 count bottle (NDC 16714-110-01) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Ipca Laboratories Limited 200 mg, 100 count bottle (NDC 76385-144-01) Resolved
Hydroxychloroquine Sulfate Tab 2020-06-26 2020-03-31 Accord Healthcare Inc. 200 mg, 500 count bottle (NDC 16729-485-16) Resolved
Indacterol Maleate (Arcapta Ne 2020-03-10 2020-03-10 Sunovion Pharmaceuticals Inc. 75mcg (NDCs 63402-675-06 and 63402-675-30) To be Discontinued
Indacterol Maleate and Glycopy 2020-03-10 2020-03-10 Sunovion Pharmaceuticals Inc. 15.6mcg; 27.5mcg (NDCs 63402-681-06, 63402-681-12, and 63402-681-60) To be Discontinued
Indinavir (CRIXIVAN) Capsules 2020-03-31 2020-03-31 Merck Sharp & Dohme Corp. 400 mg capsules, unit-of-use bottles of 180 (with desiccant)(NDC 0006-0573-62) To be Discontinued
Isocarboxazid Tablets 2020-01-10 2018-05-15 Validus Pharmaceuticals LLC 10mg (NDC 30698-032-01) Resolved
Latanoprost Ophthalmic Solutio 2020-04-06 2019-03-19 Sandoz 2.5 mL Bottle (NDC 61314-547-01) Resolved
Latanoprost Ophthalmic Solutio 2020-04-06 2019-03-19 Pfizer Pharmaceuticals 2.5 mL fill, 0.005% (50 mcg/mL): Package of 1 bottle (NDC 59762-0333-2) Resolved
Latanoprost Ophthalmic Solutio 2020-04-06 2019-03-19 Bausch Health 2.5 mL fill, 0.005% (50 mcg/mL): Package of 1 bottle (NDC 24208-463-25) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot 3.75 mg PDS kit (NDC 0074-3641-03) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot Ped, 3Month, 11.25 mg kit (NDC 0074-3379-03) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot Ped, 3Month, 30 mg kit (NDC 0074-9694-03) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot, 3Month, 11.25 mg PDS kit (NDC 0074-3663-03) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot, 3Month, 22.5 mg PDS kit (NDC 0074-3346-03) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot, 4Month, 30 mg PDS kit (NDC 0074-3683-03) Resolved
Leuprolide Acetate (Lupron Dep 2020-01-09 2019-12-10 Abbvie Lupron Depot, 6Month 45 mg PDS kit (NDC 0074-3473-03) Resolved
Levocetirizine Dihydrochloride 2020-01-21 2020-01-21 Apotex Corp. 5 mg tablets (NDCs 60505-3713-9 and 60505-3713-5) To be Discontinued
Levofloxacin Tablets 2020-02-26 2020-02-26 Sandoz 250 mg 100 count bottle (NDC 0781-5790-01) To be Discontinued
Levofloxacin Tablets 2020-02-26 2020-02-26 Sandoz 250 mg 50 count bottle (NDC 0781-5790-50) To be Discontinued
Levofloxacin Tablets 2020-02-26 2020-02-26 Sandoz 500 mg 50 count bottle (NDC 0781-5791-50) To be Discontinued
Levofloxacin Tablets 2020-02-26 2020-02-26 Sandoz 500 mg 100 count bottle (NDC 0781-5791-01) To be Discontinued
Levofloxacin Tablets 2020-02-26 2020-02-26 Sandoz 750 mg 20 count bottle (NDC 0781-5792-20) To be Discontinued
Levofloxacin Tablets 2020-02-26 2020-02-26 Sandoz 750 mg 50 count bottle (NDC 0781-5792-50) To be Discontinued
Levoleucovorin Calcium Injecti 2020-05-20 2020-05-20 Teva Pharmaceuticals 10 mg/ml (NDC 45963-762-57) To be Discontinued
Medroxyprogesterone Acetate (P 2020-02-12 2020-02-12 Pfizer Pharmaceuticals 10 mg, bottles of 500 (NDC 0009-0050-11) To be Discontinued
Metformin Hydrochloride Extend 2020-06-24 2020-06-24 Teva Pharmaceuticals 750mg tablets (NDC 2037-577-10) and (NDC 62037-577-01 ) To be Discontinued
Metformin Hydrochloride Extend 2020-06-24 2020-06-24 Teva Pharmaceuticals 500mg tablets (NDC 62037-571-01) and (NDC 62037-571-10) To be Discontinued
Metformin Hydrochloride Tablet 2020-04-15 2020-04-15 Sandoz 500 mg, bottle count 100 (NDC 42806-213-01) To be Discontinued
Metformin Hydrochloride Tablet 2020-04-15 2020-04-15 Sandoz 500 mg, bottle count 500 (NDC 42806-213-05) To be Discontinued
Metformin Hydrochloride Tablet 2020-04-15 2020-04-15 Sandoz 500 mg, bottle count 1000 (NDC 42806-213-10) To be Discontinued
Metformin Hydrochloride Tablet 2020-04-15 2020-04-15 Sandoz 850 mg, bottle count 100 (NDC 42806-215-01) To be Discontinued
Metformin Hydrochloride Tablet 2020-04-15 2020-04-15 Sandoz 850 mg, bottle count 500 (NDC 42806-215-05) To be Discontinued
Metformin Hydrochloride Tablet 2020-04-15 2020-04-15 Sandoz 1000 mg, bottle count 500 (NDC 42806-221-05) To be Discontinued
Methscopolamine Bromide Tablet 2020-01-27 2020-01-27 Par Pharmaceutical 5 mg tablets, bottle of 60 (NDC 64376-604-61) To be Discontinued
Methscopolamine Bromide Tablet 2020-01-27 2020-01-27 Par Pharmaceutical 2.5 mg tablets, bottle of 100 (NDC 64376-603-01) To be Discontinued
Minocycline Hydrochloride Exte 2020-03-24 2020-03-24 Teva Pharmaceuticals 55 mg 30 count (NDC 00093-7741-56) To be Discontinued
Minocycline Hydrochloride Exte 2020-03-24 2020-03-24 Teva Pharmaceuticals 115 mg 30 count (NDC 00093-2133-56) To be Discontinued
Minocycline Hydrochloride Exte 2020-03-24 2020-03-24 Teva Pharmaceuticals 65 mg 30 count (NDC 00093-2134-56) To be Discontinued
Minocycline Hydrochloride Exte 2020-03-24 2020-03-24 Teva Pharmaceuticals 105 mg 30 count (NDC 00093-7743-56) To be Discontinued
Minocycline Hydrochloride Exte 2020-03-24 2020-03-24 Teva Pharmaceuticals 80 mg 30 count (NDC 00093-7742-56) To be Discontinued
Morphine Sulfate Injection, US 2020-04-30 2018-12-06 ICU Medical, Inc. 1mg/mL 30mL PCA glass vial (NDC 0409-2029-02) To be Discontinued
Mycophenolic Acid Delayed Rele 2020-03-11 2020-03-11 Teva Pharmaceuticals 180mg tablets (NDC 0093-7031-89) To be Discontinued
Mycophenolic Acid Delayed Rele 2020-03-11 2020-03-11 Teva Pharmaceuticals 360mg tablets (NDC 0093-7032-89) To be Discontinued
Nelarabine (Arranon) Injection 2020-01-07 2018-10-30 Novartis 250 mg/50 mL (NDC 0078-0683-06) Resolved
Nevirapine (Viramune) Tablets 2020-05-29 2020-05-29 Boehringer Ingelheim Pharmaceu 200 mg tablets (NDC 0597-0046-60) To be Discontinued
Nevirapine Extended Release Ta 2020-01-24 2019-01-31 Sandoz 400 mg, bottle of 30 tablets (NDC 0781-5893-31) To be Discontinued
Nevirapine Extended Release Ta 2020-01-24 2019-01-31 Sandoz 400 mg, bottle of 500 tablets (NDC 0781-5893-05) To be Discontinued
Nizatidine Capsules 2020-03-09 2020-03-09 Glenmark Pharmaceuticals 150 mg, 60 count bottle (NDC 68462-0425-60) To be Discontinued
Nizatidine Capsules 2020-03-09 2020-03-09 Glenmark Pharmaceuticals 300 mg, 30 count bottle (NDC 68462-0426-30) To be Discontinued
Nizatidine Capsules 2020-07-06 2020-03-27 Teva Pharmaceuticals 300 mg, 30 count bottle (NDC 0591-3138-30) Current Supply Interruption Other
Nizatidine Capsules 2020-07-06 2020-03-27 Teva Pharmaceuticals 150 mg, 60 count bottle (NDC 0591-3137-60) Current Supply Interruption Other
Nizatidine Capsules 2020-03-27 2020-03-27 Glenmark Pharmaceuticals 300 mg, 30 count bottle (NDC 68462-0426-30) Current Unavailable
Nizatidine Capsules 2020-03-27 2020-03-27 Glenmark Pharmaceuticals 150 mg, 60 count bottle (NDC 68462-0425-60) Current Unavailable
Nystatin Oral Suspension 2020-05-06 2019-01-08 Wockhardt Nystatin Oral Solution 100,000 units/1mL; 473 mL bottles (NDC 60432-0537-16) Resolved
Nystatin Oral Suspension 2020-05-06 2019-01-08 Wockhardt Nystatin Oral Solution 100,000 units/1mL; 60 mL bottles (NDC 60432-0537-60) Resolved
Nystatin Oral Suspension 2020-05-06 2019-01-08 VistaPharm, Inc. Nystatin Oral Suspension, USP 500,000 units/5 ml; 5mL unit dose cup; 50 unit dose cups/ case (NDC 66689-037-50) Resolved
Nystatin Oral Suspension 2020-05-06 2019-01-08 VistaPharm, Inc. Nystatin Oral Suspension, USP 500,000 units/5 ml; 5mL unit dose cup; 100 unit dose cups/ case (NDC 66689-037-99) Resolved
Nystatin Oral Suspension 2020-05-06 2019-01-08 VistaPharm, Inc. Nystatin Oral Suspension, USP 100,000 units/ml; 60 mL Bottle (NDC 66689-008-02) Resolved
Nystatin Oral Suspension 2020-05-06 2019-01-08 VistaPharm, Inc. Nystatin Oral Suspension, USP 100,000 units/ml; 480 mL Bottle (NDC 66689-008-16) Resolved
Nystatin Oral Suspension 2020-05-06 2019-01-08 Pharmaceutical Associates, Inc Nystatin Oral Suspension, USP 500,000 Units/5 mL 5 mL Unit Dose Cups Case of 40 – 5 mL UDC (NDC 00121-4810-40); Case of 100 – 5 mL UDC (NDC 00121-4810-00); 2 oz. Bottles (NDC 00121-0810-02); 16 oz. Bottles (NDC 00121-0810-16) Resolved
Ocriplasmin (Jetrea) Injection 2020-04-24 2020-04-24 Thrombogenics, Inc. 1.25 mg/ml (NDC 24856-002-01) To be Discontinued
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Aurobindo Pharma 5mg, 30 ct. (NDC 65852-0741-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Aurobindo Pharma 20mg, 30 ct. (NDC 65862-0742-30) Resolved API Supply Issue
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Aurobindo Pharma 20mg, 90 ct. (NDC 65862-0742-90) Resolved API Supply Issue
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Aurobindo Pharma 40mg, 30 ct. (NDC 65862-0743-30) Resolved API Supply Issue
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Aurobindo Pharma 40mg., 90 ct. (NDC 65862-0743-90) Resolved API Supply Issue
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alembic Pharmaceuticals 5mg, Bottle of 30 counts (NDC 62332-131-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alembic Pharmaceuticals 20mg, Bottle of 30 counts (NDC 62332-132-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alembic Pharmaceuticals 20mg, Bottle of 90 counts (NDC 62332-132-90) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alembic Pharmaceuticals 40mg, Bottle of 30 counts (NDC 62332-133-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alembic Pharmaceuticals 40mg, Bottle of 90 counts (NDC 62332-133-90) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Glenmark Pharmaceuticals 5mg (NDC 68462-0436-30) Resolved API shortage
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Glenmark Pharmaceuticals 20mg (NDC 68462-0437-30) Resolved API shortage
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Glenmark Pharmaceuticals 20mg (NDC 68462-0437-90) Resolved API shortage
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Glenmark Pharmaceuticals 40mg (NDC 68462-0438-30) Resolved API shortage
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Glenmark Pharmaceuticals 40mg (NDC 68462-0438-90) Resolved API shortage
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Mylan Pharmaceuticals Inc. Olmesartan Medoxomil 5mg T 30s (NDC 0378-7012-93) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Mylan Pharmaceuticals Inc. Olmesartan Medoxomil 20mg T 30s (NDC 0378-7112-93) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Mylan Pharmaceuticals Inc. Olmesartan Medoxomil 20mg T 90s (NDC 0378-7112-77) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Mylan Pharmaceuticals Inc. Olmesartan Medoxomil 40mg T 30s (NDC 0378-7124-93) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Mylan Pharmaceuticals Inc. Olmesartan Medoxomil 40mg T 90s (NDC 0378-7124-77) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Accord Healthcare Inc. 5mg, 30T (NDC 1672-9320-10) Resolved Limited API availability
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Accord Healthcare Inc. 5mg, 90T (NDC 1672-9320-15) Resolved Limited API availability
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Accord Healthcare Inc. 20mg, 30T (NDC 1672-9321-10) Resolved Limited API availability
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Accord Healthcare Inc. 20mg, 90T (NDC 1672-9321-15) Resolved Limited API availability
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Accord Healthcare Inc. 40mg, 30T (NDC 1672-9322-10) Resolved Limited API availability
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Accord Healthcare Inc. 40mg, 90T (NDC 1672-9322-15) Resolved Limited API availability
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Torrent Pharma Inc. 5mg tablet (NDC 13668-248-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Torrent Pharma Inc. 20mg tablet (NDC 13668-249-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Torrent Pharma Inc. 20mg tablet (NDC 13668-249-90) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Torrent Pharma Inc. 40mg tablet (NDC 13668-250-30) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Torrent Pharma Inc. 40mg tablet (NDC 13668-250-90) Resolved
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Daiichi Sankyo, Inc. 5mg, 30 Unit (NDC 65597-101-30) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Daiichi Sankyo, Inc. 20mg, 30 Unit (NDC 65597-103-30) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Daiichi Sankyo, Inc. 20mg, 90 Unit (NDC 65597-103-90) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Daiichi Sankyo, Inc. 40mg, 30 Unit (NDC 65597-104-30) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Daiichi Sankyo, Inc. 40mg, 90 Unit (NDC 65597-104-90) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alkem Laboratories Olmesartan Medoxomil 20mg 30 Tabs (NDC 67877-0446-30) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alkem Laboratories Olmesartan Medoxomil 20mg 90 Tabs (NDC 67877-0446-90) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alkem Laboratories Olmesartan Medoxomil 40mg 30 Tabs (NDC 67877-0447-30) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alkem Laboratories Olmesartan Medoxomil 40mg 90 Tabs (NDC 67877-0447-90) Resolved Other
Olmesartan Medoxomil Tablets 2020-03-05 2019-03-12 Alkem Laboratories Olmesartan Medoxomil 5mg 30 Tabs (NDC 67877-0445-30) Resolved Other
Olopatadine Hydrochloride (Pat 2020-02-26 2020-02-26 Novartis 2mg/mL 5mL in 1 bottle (NDC 0065-0272-11) To be Discontinued
Olopatadine Hydrochloride (Pat 2020-02-26 2020-02-26 Novartis 2mg/mL 2.5mL in 1 bottle (NDC 0065-0272-25) To be Discontinued
Olopatadine Hydrochloride (Pat 2020-02-26 2020-02-26 Novartis 2mg/mL 2.5mL in 1 bottle (NDC 61314-272-25) To be Discontinued
Paclitaxel Injection, USP 2020-03-30 2020-03-06 Fresenius Kabi USA, LLC 30 mg/5 mL (6 mg/mL) MDV (NDC 63323-763-05) To be Discontinued
Paclitaxel Injection, USP 2020-03-30 2020-03-30 Mylan Institutional 30 mg in 5 mL (6 mg/mL), multi-dose vial (NDC 67457-471-52) To be Discontinued
Paclitaxel Injection, USP 2020-03-30 2020-03-30 Mylan Institutional 300 mg in 50 mL (6 mg/mL), multi-dose vial (NDC 67457-434-51) To be Discontinued
Penicillin V Potassium Tablets 2020-03-19 2020-03-04 Sandoz 500 mg, 100 tablets (NDC 0781-1655-01) To be Discontinued
Penicillin V Potassium Tablets 2020-03-19 2020-03-04 Sandoz 500 mg, 1000 tablets (NDC 0781-1655-10) To be Discontinued
Penicillin V Potassium Tablets 2020-03-19 2020-03-04 Sandoz 250 mg, 100 tablets (NDC 0781-1205-01) To be Discontinued
Penicillin V Potassium Tablets 2020-03-19 2020-03-04 Sandoz 250 mg, 1000 tablets (NDC 0781-1205-10) To be Discontinued
Peritoneal Dialysis Solutions 2020-03-02 2016-01-20 Baxter Healthcare Peritoneal Dialysis Solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD) therapy (Dianeal and Extraneal) Resolved
Peritoneal Dialysis Solutions 2020-03-02 2014-08-08 Baxter Healthcare Peritoneal Dialysis Solutions for Automated Peritoneal Dialysis (APD) therapy (Dianeal and Extraneal) Resolved
Peritoneal Dialysis Solutions 2020-03-02 2014-08-08 Fresenius Medical Care North A Peritoneal Dialysis Solutions (Delflex and Stay Safe) Resolved
Pioglitazone Hydrochloride and 2020-02-10 2020-02-10 Sandoz 500mg;15mg tablets (NDC 0781-5626-60) To be Discontinued
Pioglitazone Hydrochloride and 2020-02-10 2020-02-10 Sandoz 850mg;15mg tablets (NDC 0781-5627-60) To be Discontinued
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 2.25 g, single dose vial, box of 10 (NDC 64679-034-01 Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Apollo Pharmaceuticals Inc. 2.25 g, single dose vial, box of 10 (NDC 61990-0110-2) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Apollo Pharmaceuticals Inc. 4.5 g, single dose vial, box of 10 (NDC 61990-0130-2) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 2.25 g, single dose vial, box of 10 (NDC 70860-120-20); distributed by Athenex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Apollo Pharmaceuticals Inc. 3.375 g, single dose vial, box of 10 (NDC 61990-0120-2) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Apollo Pharmaceuticals Inc. 13.5 g, pharmacy bulk vial (NDC 61990-0140-1) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Apollo Pharmaceuticals Inc. 40.5 g, pharmacy bulk vial (NDC 61990-0150-1) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 3.375 g, single dose vial, box of 10 (NDC 70860-121-30); distributed by Athenex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 4.5 g, single dose vial, box of 10 (NDC 70860-122-50); distributed by Athenex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 40.5 g, pharmacy bulk bottle (NDC 70860-123-99); distributed by Athenex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 3.375 g, single dose vial, box of 10 (NDC 0409-3378-13) ADD-Vantage; distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 4.5 g, single dose vial, box of 10 (NDC 0409-3379-04) ADD-Vantage; distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 2.25 g, single dose vial, box of 10 (NDC 0409-3383-02); distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 3.375 g, single dose vial, box of 10 (NDC 0409-3385-13); distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 4.5 g, single dose vial, box of 10 (NDC 0409-3390-04); distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 13.5 g, pharmacy bulk bottle (NDC 0409-2999-14); distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Fresenius Kabi USA, LLC 2.25 g, single-dose vial (NDC 63323-981-21) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 3.375 g, single dose vial, box of 10 (NDC 64679-056-01) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 3.375 g, single dose vial (NDC 64679-056-02) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 40.5 g, pharmacy bulk vial, box of 10 (NDC 64679-679-02) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Qilu Tianhe Pharmaceutical Co. 2.25 g, single dose vial, box of 10 (NDC 60505-6156-4); distributed by Apotex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Qilu Tianhe Pharmaceutical Co. 3.375 g, single dose vial, box of 10 (NDC 60505-6157-4); distributed by Apotex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Qilu Tianhe Pharmaceutical Co. 4.5 g, single dose vial, box of 10 (NDC 60505-6159-4); distributed by Apotex Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 2.25 g, single dose vial, box of 10 (NDC 0781-9210-95) Novaplus Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 4.5 g, single dose vial, box of 10 (NDC 0781-9214-95) Novaplus Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 3.375 g, single dose vial, box of 10 (NDC 0781-9213-95) Novaplus Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Pfizer Pharmaceuticals Zosyn; 2.25 g/50 mL, frozen IV bag (NDC 0206-8860-02) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Pfizer Pharmaceuticals Zosyn; 3.375 g/50 mL, frozen IV bag (NDC 0206-8861-02) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Pfizer Pharmaceuticals Zosyn; 4.5 g/100 mL, frozen IV bag (NDC 0206-8862-02) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Aurobindo Pharma 2.25 g, single dose vial, box of 10 (NDC 55150-119-30); distributed by AuroMedics Pharma LLC Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Aurobindo Pharma 3.375 g, single dose vial, box of 10 (NDC 55150-120-30); distributed by AuroMedics Pharma LLC Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Aurobindo Pharma 4.5 g, single dose vial, box of 10 (NDC 55150-121-50); distributed by AuroMedics Pharma LLC Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 2.25 g, single dose vial, box of 10 (NDC 63323-309-20); distributed by Fresenius Kabi Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Fresenius Kabi USA, LLC 3.375 g, single dose vial, box of 10 (NDC 63323-983-21) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Fresenius Kabi USA, LLC 4.5 g, single dose vial, box of 10 (NDC 63323-982-52) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 40.5 g, pharmacy bulk bottle (NDC 63323-304-74); distributed by Fresenius Kabi Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 2.25 g, single dose vial, box of 10 (NDC 0409-3374-02) ADD-Vantage; distributed by Hospira Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Aurobindo Pharma 2.25 g, single dose vial, box of 10 (NDC 25021-164-30); distributed by Sagent Pharmaceuticals Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Aurobindo Pharma 3.375 g, single dose vial, box of 10 (NDC 25021-165-30); distributed by Sagent Pharmaceuticals Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Aurobindo Pharma 4.5 g, single dose vial, box of 10 (NDC 25021-166-48); distributed by Sagent Pharmaceuticals Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 2.25 g, single dose vial, box of 10 (NDC 44567-801-10); distributed by WG Critical Care Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 3.375 g, single dose vial, box of 10 (NDC 44567-802-10); distributed by WG Critical Care Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 4.5 g, single dose vial, box of 10 (NDC 44567-803-10); distributed by WG Critical Care Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Istituto Biochimico Italiano S 40.5 g, pharmacy bulk bottle (NDC 44567-804-01); distributed by WG Critical Care Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 4.5 g, single dose vial, box of 10 (NDC 0781-3114-95) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 3.375 g, single dose vial, box of 10 (NDC 0781-3113-95) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Sandoz 2.25 g, single dose vial, box of 10 (NDC 0781-3110-95) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Mylan Institutional 3.375 g, single dose vial, box of 10 (NDC 67457-522-37) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Mylan Institutional 4.5 g, single dose vial, box of 10 (NDC 67457-523-45) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Mylan Institutional 2.25 g, single dose vial, box of 10 (NDC 67457-521-22) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 4.5 g, single dose vial, box of 10 (NDC 64679-012-01) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 4.5 g, single dose vial (NDC 64679-012-02) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 40.5 g, pharmacy bulk vial (NDC 64679-679-01) Resolved
Piperacillin and Tazobactam (Z 2020-02-21 2014-04-02 Wockhardt 2.25 g, single dose vial (NDC 64679-034-02) Resolved
Pramipexole Dihydrochloride Ex 2020-01-27 2020-01-27 Endo Pharmaceuticals, Inc. 4.5 mg tablets (NDC 10370-255-11) To be Discontinued
Prinivil Tablets 2020-02-20 2020-02-20 Merck Sharp & Dohme Corp. 10-mg tablets, unit-of-use bottle/90 (NDC0006-0106-54) To be Discontinued
Prinivil Tablets 2020-02-20 2020-02-20 Merck Sharp & Dohme Corp. 20-mg tablets, unit-of-use bottle/90 (NDC 0006-0207-54) To be Discontinued
Promethazine Suppository 2020-04-28 2020-04-28 Teva Pharmaceuticals 25 mg/1 unit, (NDC 0591-2992-39 ) To be Discontinued
Promethazine Suppository 2020-04-28 2020-04-28 Teva Pharmaceuticals 12.5 mg/1 unit, (NDC 0591-2985-39) To be Discontinued
Pyrazinamide Tablets, USP 2020-04-20 2020-04-20 DAVA Pharmaceuticals Inc. 500 mg, Bottle of 100 (NDC 67253-660-10) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Mylan Institutional Ranitidine Injection 25 mg/mL, 2ml vial; 10 pack; (NDC 67457-397-99) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Mylan Institutional Ranitidine Injection 25 mg/mL, 6 mL vial; 1 pack; (NDC 67457-398-62) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Zydus Pharmaceuticals USA Inc. Ranitidine HCl Injection 25mg/mL (10x2mL SD vials)(NDC 68382-422-02) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Zydus Pharmaceuticals USA Inc. Ranitidine HCl Injection 25mg/mL (6mL MD vial)(NDC 68382-423-06) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Teligent Pharma, Inc. ZANTAC INJECTABLE 25MG/ML 2ML VIAL (NDC 52565-101-01) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Teligent Pharma, Inc. ZANTAC INJECTABLE 25MG/ML 40ML VIAL (NDC 52565-096-01) To be Discontinued
Ranitidine Injection, USP 2020-04-03 2016-12-08 Teligent Pharma, Inc. ZANTAC INJECTABLE 25MG/ML 6ML VIAL (NDC 52565-102-01) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Glenmark Pharmaceuticals 150mg 60 count bottle (NDC 68462-248-60) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Glenmark Pharmaceuticals 150mg 100 count bottle (NDC 68462-248-01) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Glenmark Pharmaceuticals 150mg 500 count bottle (NDC 68462-248-05) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Glenmark Pharmaceuticals 300mg 30 count bottle (NDC 68462-249-30) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Glenmark Pharmaceuticals 300mg 100 count bottle (NDC 68462-249-01) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Glenmark Pharmaceuticals 300mg 250 count bottle (NDC 68462-249-20) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Appco Pharma LLC 150mg 60 count bottle (NDC 62559-690-60) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Appco Pharma LLC 150mg 500 count bottle (NDC 62559-690-05) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Appco Pharma LLC 300mg 30 count bottle (NDC 62559-691-30) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Dr. Reddy's Laboratories, Inc. 150mg 60 count bottle (NDC 5511112960) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Dr. Reddy's Laboratories, Inc. 150mg 500 count bottle (NDC 5511112905) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Dr. Reddy's Laboratories, Inc. 300mg 30 count bottle (NDC 5511113030) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Dr. Reddy's Laboratories, Inc. 300mg 100 count bottle (NDC 5511113001) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Novitium Pharma LLC 150 mg, Bottle of 60 capsules (NDC 70954-001-20) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Novitium Pharma LLC 150 mg, Bottle of 500 capsules (NDC 70954-001-40) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Novitium Pharma LLC 300 mg, Bottle of 30 capsules (NDC 70954-002-10) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Novitium Pharma LLC 300 mg, Bottle of 100 capsule (NDC 70954-002-40) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Ajanta Pharma USA Inc 150 mg 60’s count bottle (NDC 27241-109-06) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Ajanta Pharma USA Inc 150 mg 500’s count bottle (NDC 27241-109-50) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Ajanta Pharma USA Inc 300 mg 30’s count bottle (NDC 27241-110-03) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Ajanta Pharma USA Inc 300 mg 100’s count bottle (NDC 27241-110-10) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 150 mg, 60 count bottle (NDC 64380-0803-03) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 150 mg, 100 count bottle (NDC 64380-0803-06) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 150 mg, 500 count bottle (NDC 64380-0803-07) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 150 mg, 1000 count bottle (NDC 64380-0803-08) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 300 mg, 30 count bottle (NDC 64380-0804-04) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 300 mg, 100 count bottle (NDC 64380-0804-06) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Strides Pharma Inc. 300 mg, 250 count bottle (NDC 64380-0804-38) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 150 mg, 60 count (NDC 65162-253-06) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 150 mg, 100 count (NDC 65162-253-10) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 150 mg, 180 count (NDC 65162-253-18) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 150 mg, 500 count (NDC 65162-253-50) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 150 mg, 1000 count (NDC 65162-253-11) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 150 mg, 1000 count (NDC 65162-253-11) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 300 mg, 30 count (NDC 65162-254-03) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 300 mg, 100 count (NDC 65162-254-10) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 300 mg, 250 count (NDC 65162-254-25) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Amneal Pharmaceutical 300 mg, 250 count (NDC 53746-254-02) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Sandoz 150 mg 500 ct bottle (NDC 0781-2855-05) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Sandoz 150 mg 60 ct bottle (NDC 0781-2855-60) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-03 2020-01-07 Sandoz 300 mg 30 ct bottle (NDC 0781-2865-31) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-30 2020-01-07 Teva Pharmaceuticals 150 mg / 300 mg (NDC 0172-4357-49) and (NDC 0172-4358-46) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-30 2020-01-07 Teva Pharmaceuticals 150 mg/1 unit (NDC 0172-4357-70) To be Discontinued
Ranitidine Tablets/Capsules 2020-04-30 2020-01-07 Teva Pharmaceuticals 300 mg/1 unit (NDC 0172-4358-60) To be Discontinued
Ranolazine Extended Release Ta 2020-07-06 2020-07-06 Teva Pharmaceuticals 500 mg (NDC 45963-418-50) To be Discontinued
Ranolazine Extended Release Ta 2020-07-06 2020-07-06 Teva Pharmaceuticals 1000 mg (NDC 45963-419-50) To be Discontinued
Remifentanil (Ultiva) Lyophili 2020-03-02 2018-02-06 Fresenius Kabi USA, LLC 1 mg per vial, SDV (NDC 63323-723-03) Resolved
Remifentanil (Ultiva) Lyophili 2020-03-02 2018-02-06 Fresenius Kabi USA, LLC 2 mg per vial, SDV (NDC 63323-724-05) Resolved
Remifentanil (Ultiva) Lyophili 2020-03-02 2018-02-06 Fresenius Kabi USA, LLC 5 mg per vial, SDV (NDC 63323-725-10) Resolved
Remifentanil (Ultiva) Lyophili 2020-03-02 2018-02-06 Mylan Institutional 1 mg (NDC 67457-198-03) Resolved
Remifentanil (Ultiva) Lyophili 2020-03-02 2018-02-06 Mylan Institutional 2 mg (NDC 67457-198-05) Resolved
Remifentanil (Ultiva) Lyophili 2020-03-02 2018-02-06 Mylan Institutional 5 mg (NDC 67457-198-10) Resolved
Rifampin (Rifadin) Capsules 2020-06-15 2020-06-15 Sanofi-Aventis 150 mg capsules (NDC 0068-0510-30) To be Discontinued
Rifampin (Rifadin) Capsules 2020-06-15 2020-06-15 Sanofi-Aventis 300 mg capsules (NDC 0068-0508-60) To be Discontinued
Rifampin/Isoniazid (Rifamate) 2020-06-15 2020-06-15 Sanofi-Aventis 150 mg/300 mg capsules (NDC 0068-0509-60) To be Discontinued
Rifampin/Isoniazid/Pyrazinamid 2020-06-15 2020-06-15 Sanofi-Aventis 150 mg/300 mg/120 mg tablets (NDC 0088-0576-41) To be Discontinued
Rifapentine Tablets 2020-03-25 2020-03-25 Sanofi Rifapentine (Piftin) Tablets, 150 mg (NDC 0088-2102-24) Current On allocation with intermittent supply. Demand increase for the drug
Rivastigmine Tartrate Capsules 2020-03-10 2020-03-10 Teva Pharmaceuticals 1.5 mg capsules, 60 count (NDC 0591-3208-60) To be Discontinued
Rivastigmine Tartrate Capsules 2020-03-10 2020-03-10 Teva Pharmaceuticals 3 mg capsules, 60 count (NDC 0591-3209-60) To be Discontinued
Rivastigmine Tartrate Capsules 2020-03-10 2020-03-10 Teva Pharmaceuticals 4.5 mg capsules, 60 count (NDC 0591-3210-60) To be Discontinued
Rivastigmine Tartrate Capsules 2020-03-10 2020-03-10 Teva Pharmaceuticals 6 mg capsules, 60 count (NDC 0591-3211-60) To be Discontinued
Sodium Lactate Injection, USP 2020-01-09 2020-01-09 Hospira, Inc. 50 mEq/10 mL (5 mEq/10 mL); Single Dose Plastic Fliptop Vial (NDC 00409-6664-02) To be Discontinued
Somatropin Recombinant (Humatr 2020-07-07 2020-07-07 Eli Lilly and Co. 5 mg kit (NDC 0002-7335-11) contains 5 mg/mL in 1 vial (NDC 0002-7349-01) of Humatrope and 5 mL in 1 vial (NDC 0002-7336-01) of Sterile Diluent To be Discontinued
Sumatriptan Succinate (Imitrex 2020-04-03 2020-04-03 GlaxoSmithKline 6 mg, single dose vial (NDC 0173-0449-02) To be Discontinued
Sumatriptan Succinate Injectio 2020-02-21 2020-02-21 Mylan Institutional 6 mg/0.5 mL, single-dose vial (NDC 67457-880-05) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 5 mg child-resistent sachets, 5 count (NDC 0085-3004-03) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 5 mg child-resistent sachets, 14 count (NDC 0085-3004-04) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 20 mg child-resistent sachets, 5 count (NDC 0085-1519-03) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 20 mg child-resistent sachets, 14 count (NDC 0085-1519-04) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 140 mg child-resistent sachets, 5 count (NDC 0085-1425-03) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 180 mg child-resistent sacehts, 14 count (NDC 0085-1430-04) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 5 mg, 5 capsules (NDC 0781-2691-75) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 5 mg, 14 capsules (NDC 0781-2691-44) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 20 mg, 5 capsules (NDC 0781-2692-75) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 20 mg, 14 capsules (NDC 0781-2692-44) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 100 mg, 5 capsules (NDC 0781-2693-75) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 100 mg, 14 capsules (MDC 0781-2693-44) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 140 mg, 5 capsules (NDC 0781-2694-75) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 140 mg, 14 capsules (NDC 0781-2694-44) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 180 mg, 5 capsules (NDC 0781-2695-75) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 180 mg, 14 capsules (NDC 0781-2695-44) To be Discontinued
Temozolomide (TEMODAR) Capsule 2020-01-23 2020-01-23 Merck Sharp & Dohme Corp. 250 mg, 5 capsules (NDC 0781-2696-75) To be Discontinued
Temozolomide Capsules 2020-05-08 2020-05-08 Teva Pharmaceuticals 5 mg (NDCs 0093-7599-41 and 0093-7599-57) To be Discontinued
Temozolomide Capsules 2020-05-08 2020-05-08 Teva Pharmaceuticals 20 mg (NDCs 0093-7600-41 and 0093-7600-57) To be Discontinued
Temozolomide Capsules 2020-05-08 2020-05-08 Teva Pharmaceuticals 100 mg (NDCs 0093-7601-41 and 0093-7601-57) To be Discontinued
Temozolomide Capsules 2020-05-08 2020-05-08 Teva Pharmaceuticals 140 mg (NDCs 0093-7638-41 and 0093-7638-57) To be Discontinued
Temozolomide Capsules 2020-05-08 2020-05-08 Teva Pharmaceuticals 180 mg (NDCs 0093-7639-41 and 0093-7639-57) To be Discontinued
Temozolomide Capsules 2020-05-08 2020-05-08 Teva Pharmaceuticals 250 mg (NDC 0093-7602-57) To be Discontinued
Testosterone Topical Gel 2020-04-03 2020-04-03 Endo Pharmaceuticals, Inc. 50mg/5g topical gel (NDC 0254-1012-11) To be Discontinued
Thioridazine Hydrochloride Tab 2020-01-07 2018-02-02 Mylan Pharmaceuticals Inc. 50 mg (NDC 0378-0616-01) Resolved
Thioridazine Hydrochloride Tab 2020-01-07 2018-02-02 Mylan Pharmaceuticals Inc. 100 mg (NDC 0378-0618-01) Resolved
Thioridazine Hydrochloride Tab 2020-01-07 2018-02-02 Mylan Pharmaceuticals Inc. 10 mg (NDC 0378-0612-01) Resolved
Thioridazine Hydrochloride Tab 2020-01-07 2018-02-02 Mylan Pharmaceuticals Inc. 25 mg (NDC 0378-0614-01) Resolved
Tramadol Hydrochloride (Ultram 2020-04-01 2020-04-01 Janssen Pharmaceuticals 50 mg/1 unit (NDC 50458-659-60) To be Discontinued
Trazodone Tablets 2020-04-20 2020-04-20 Accord Healthcare Inc. 50 mg tablets, bottle of 100 (NDC 16729-299-01); bottle of 1000 (NDC 16729-299-17) To be Discontinued
Trazodone Tablets 2020-04-20 2020-04-20 Accord Healthcare Inc. 100 mg tablets, bottle of 100 (NDC 16729-300-01); bottle of 1000 (NDC 16729-300-17) To be Discontinued
Trazodone Tablets 2020-04-20 2020-04-20 Accord Healthcare Inc. 150 mg tablets, bottle of 100 (NDC 16729-301-01); bottle of 1000 (NDC 16729-301-17) To be Discontinued
Trazodone Tablets 2020-04-20 2020-04-20 Accord Healthcare Inc. 300 mg tablets, bottle of 100 (NDC 16729-302-01) To be Discontinued
Valsartan Tablets 2020-03-04 2018-08-16 Amneal Pharmaceutical 40 mg, 30 ct bottle (NDC 65162-837-03); 60 ct bottle (NDC 65162-837-06); 500 ct bottle (NDC 65162-837-50) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-16 Amneal Pharmaceutical 80 mg, 90 ct bottle (NDC 65162-838-09); 500 ct bottle (NDC 65162-838-50); 1000 ct bottle (NDC 65162-838-11) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-16 Amneal Pharmaceutical 160 mg, 90 ct bottle (NDC 65162-839-09); 500 ct bottle (NDC 65162-839-50); 1000 ct bottle (NDC 65162-839-11) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-16 Amneal Pharmaceutical 320 mg, 90 ct bottle (NDC 65162-840-09); 500 ct bottle (NDC 65162-840-50); 1000 ct bottle (NDC 65162-840-11) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Camber Pharmaceuticals Inc. 40 mg (NDC 31722-745-30) Resolved Shortage of an active ingredient
Valsartan Tablets 2020-03-04 2018-08-03 Camber Pharmaceuticals Inc. 80 mg (NDC 31722-746-90) Resolved Shortage of an active ingredient
Valsartan Tablets 2020-03-04 2018-08-03 Camber Pharmaceuticals Inc. 160 mg (NDC 31722-746-90) Resolved Shortage of an active ingredient
Valsartan Tablets 2020-03-04 2018-08-03 Camber Pharmaceuticals Inc. 320 mg (NDC 31722-748-90) Resolved Shortage of an active ingredient
Valsartan Tablets 2020-03-04 2018-08-03 Ohm Laboratories Inc. 40 mg (NDC 51660-140-30) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Ohm Laboratories Inc. 80 mg (NDC 51660-141-90) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Ohm Laboratories Inc. 160 mg (NDC 51660-142-90) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Ohm Laboratories Inc. 320 mg (NDC 51660-143-90) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Macleods Pharmaceuticals Limit Valsartan Tablets 40mg x 30's Bottle Pack (NDC 33342006207) Resolved Available
Valsartan Tablets 2020-03-04 2018-08-03 Macleods Pharmaceuticals Limit Valsartan Tablets 80mg x 90's Bottle Pack (NDC 33342006310) Resolved Available
Valsartan Tablets 2020-03-04 2018-08-03 Macleods Pharmaceuticals Limit Valsartan Tablets 160mg x 30's Bottle Pack (NDC 33342006410) Resolved Available
Valsartan Tablets 2020-03-04 2018-08-03 Macleods Pharmaceuticals Limit Valsartan Tablets 320mg x 30's Bottle Pack (NDC 33342006510) Resolved Available
Valsartan Tablets 2020-03-04 2018-08-03 Solco Healthcare US, LLC 40mg 30’s (NDC 43547-0367-03) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Solco Healthcare US, LLC 160mg 90’s (NDC 43547-0369-09) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Solco Healthcare US, LLC 80mg 90’s (NDC 43547-0368-09) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Solco Healthcare US, LLC 320mg 90’s (NDC 43547-0370-09) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Aurobindo Pharma Valsartan Tablets USP 40 mg. - 30/Bottle (NDC 65862-0570-30) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Aurobindo Pharma Valsartan Tablets USP 80 mg. - 90/Bottle (NDC 65862-0571-90) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Aurobindo Pharma Valsartan Tablets USP 160 mg. - 90/Bottle (NDC 65862-0572-90) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Aurobindo Pharma Valsartan Tablets USP 320 mg. - 90/Bottle (NDC 65862-0573-90 ) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Mylan Pharmaceuticals Inc. 40 mg (30’s) (NDC 0378-5807-93) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Mylan Pharmaceuticals Inc. 160 mg (90’s) (NDC 0378-5814-77) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Mylan Pharmaceuticals Inc. 80 mg (90’s) (NDC 0378-5813-77) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Mylan Pharmaceuticals Inc. 320 mg (90’s) (NDC 0378-5815-77) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Jubilant Cadista Pharmaceutica 40 mg (30's) (NDC 59746-0360-30) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Jubilant Cadista Pharmaceutica 80 mg (90's) (NDC 59746-0361-90) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Jubilant Cadista Pharmaceutica 160 mg (90's) (NDC 59746-0362-90) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Jubilant Cadista Pharmaceutica 320 mg (90's) (NDC 59746-0363-90) Resolved Other
Valsartan Tablets 2020-01-16 2018-08-03 Torrent Pharma Inc. 40 mg (NDC 13668-067-30) To be Discontinued
Valsartan Tablets 2020-01-16 2018-08-03 Torrent Pharma Inc. 80 mg (NDC 13668-068-90) To be Discontinued
Valsartan Tablets 2020-01-16 2018-08-03 Torrent Pharma Inc. 160 mg (NDC 13668-069-90) To be Discontinued
Valsartan Tablets 2020-01-16 2018-08-03 Torrent Pharma Inc. 320 mg (NDC 13668-070-90) To be Discontinued
Valsartan Tablets 2020-03-04 2018-08-03 Novartis DIOVAN® scored tablets 40mg 30s 1 bottle of 30 tablets (NDC 0078-0423-15) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis DIOVAN® tablets 80mg 1 bottle of 90 tablets (NDC 0078-0358-34) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis DIOVAN® tablets 160mg 1 bottle of 90 tablets (NDC 0078-0359-34) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis DIOVAN® tablets 320mg 1 bottle of 90 count (NDC 0078-0360-34) Resolved Demand increase for the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis Valsartan Tablets 40 mg 1 bottle of 90 tablets (NDC 0781-5607-31) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis Valsartan Tablets 80 mg 1 bottle of 90 tablets (NDC 0781-5608-92) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis Valsartan Tablets 160 mg 1 bottle of 90 tablets (NDC 0781-5618-92) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Novartis Valsartan Tablets 320 mg 1 bottle of 90 tablets (NDC 0781-5619-92) Resolved Discontinuation of the manufacture of the drug
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 40 mg bottle of 30 counts (NDC 62332-044-30) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 40 mg bottle of 90 counts (NDC 62332-044-90) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 40 mg bottle of 500 counts (NDC 62332-044-71) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 80 mg bottle of 30 counts (NDC 62332-045-30) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 80 mg bottle of 90 counts (NDC 62332-045-90) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 80 mg bottle of 500 counts (NDC 62332-045-71) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 160 mg bottle of 30 counts (NDC 62332-046-30) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 160 mg bottle of 90 counts (NDC 62332-046-90) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 160 mg bottle of 500 counts (NDC 62332-046-71) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 320 mg bottle of 30 count (NDC 62332-047-30) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 320 mg bottle of 90 count (NDC 62332-047-90) Resolved Other
Valsartan Tablets 2020-03-04 2018-08-03 Alembic Pharmaceuticals 320 mg bottle of 500 counts (NDC 62332-047-71) Resolved Other
Vincristine Sulfate Injection, 2020-01-30 2019-10-16 Hospira, Inc. 1 mg/mL Single Dose Glass Fliptop Vial (NDC 61703-0309-06) Resolved
Vincristine Sulfate Injection, 2020-01-30 2019-10-16 Hospira, Inc. 2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 61703-0309-16) Resolved
Zolpidem Tartrate Extended Rel 2020-05-01 2020-05-01 Teva Pharmaceuticals 12.5 mg (NDC 0228-3482-11) To be Discontinued

One Search.

1. Search by Drug:

Enter atleast 4 letters

2. Search by Company:

Enter alteast 4 letters